TOKYO -- As Shionogi & Co. races to bring a possible coronavirus vaccine to the market next year, the Japanese drug manufacturer is considering plans to expand production capabilities before clinical trials start.
Pharmaceuticals
Japan's Shionogi primed to mass-produce coronavirus vaccine in 2021
Drugmaker rolls dice with bulking up capacity before clinical trials launch
Drugmakers are racing to develop a vaccine for the novel coronavirus, seen here in orange in a scanning electron microscope image. © U.S. National Institute of Allergy and Infectious Diseases, NIH
Read Next
Latest on Pharmaceuticals
